Open AccessRegarding “Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms”
Author(s) -
Yoshida Go J.
Publication year - 2018
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2018-0148
Subject(s) - medicine , chemotherapy , immune surveillance , immune system , oncology , ovarian cancer , programmed cell death , cancer research , cancer , immunology , apoptosis , biochemistry , chemistry
New treatment strategies for platinum‐resistant recurrent ovarian cancer are needed. Programmed cell death‐1 (PD‐1) signaling is a new target of antitumor therapy that involves immune reactivation; however, its antitumor effect on subsequent chemotherapy is unclear. Two representative cases are described here.